Reviva Pharmaceuticals, Inc. — Form D

Reviva Pharmaceuticals, Inc. of SAN JOSE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-03-21. The offering totals $12.0M, of which $12.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2013-03-21
• Form: D
• Accession: 0001552470-13-000001
• Industry: Pharmaceuticals
• Exemptions: 06
• Total offering: $12.0M
• Amount sold: $12.0M
• Investors: 82
• Date of first sale: 2013-03-07
• Security types: equity, debt
• Revenue range: Decline to Disclose
• SEC file number: 021-193724

Issuer

• Name: Reviva Pharmaceuticals, Inc.
• CIK: 0001552470
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 5941 OPTICAL COURT, SAN JOSE, CA, 95138
• Phone: 408-960-2209

Officers, directors & promoters (5)

Other filings by this issuer (3)

More

• CIK 1552470 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search